Drug Type Small molecule drug |
Synonyms WX 081, WX-081, WX081 + [1] |
Target |
Mechanism ATP synthase inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC34H33ClN2O2 |
InChIKeyMMUCHWPQRGEHDV-ZFEZZJPFSA-N |
CAS Registry1859978-72-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Rifampicin resistant tuberculosis | Phase 3 | CN | 02 Sep 2022 | |
Pulmonary Tuberculosis | Phase 3 | CN | 29 Aug 2022 | |
Multidrug resistant pulmonary tuberculosis | Phase 2 | CN | 16 Oct 2020 |